Published in
Springer Nature [academic journals on nature.com], Blood Cancer Journal, 9(10), 2020
DOI: 10.1038/s41408-020-00358-3
Links
Tools
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab
Journal article published in 2020 by
Massimo Gentile 
,
Enrica Antonia Martino,
Andrea Visentin,
Marta Coscia,
Gianluigi Reda,
Paolo Sportoletti,
Francesca Romana Mauro,
Luca Laurenti,
Marzia Varettoni,
Roberta Murru,
Annalisa Chiarenza,
Ernesto Vigna,
Francesco Mendicino,
Eugenio Lucia,
Sabrina Bossio
and other authors.
,
Enrica Antonia Martino,
Andrea Visentin,
Marta Coscia,
Gianluigi Reda,
Paolo Sportoletti,
Francesca Romana Mauro,
Luca Laurenti,
Marzia Varettoni,
Roberta Murru,
Annalisa Chiarenza,
Ernesto Vigna,
Francesco Mendicino,
Eugenio Lucia,
Sabrina Bossio
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Data provided by 